Update of Diagnosis and Targeted Therapy for ALK+ Inflammation Myofibroblastic Tumor.

Saved in:
Bibliographic Details
Title: Update of Diagnosis and Targeted Therapy for ALK+ Inflammation Myofibroblastic Tumor.
Authors: Wang QA; School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan., Chen HW; Division of Emergency and Critical Care Radiology, Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital, Chang Gung University, Linkou, Taiwan., Wu RC; Department of Pathology, Chang Gung Memorial Hospital at Linkou and Chang Gung University, Taoyuan, Taiwan., Wu CE; Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan. jiaoen@gmail.com.
Source: Current treatment options in oncology [Curr Treat Options Oncol] 2023 Dec; Vol. 24 (12), pp. 1683-1702. Date of Electronic Publication: 2023 Nov 08.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1534-6277
DOI:10.1007/s11864-023-01144-6